patuzzo sorted by
relevance

Admin12.08.2021

Before you continue to YouTube

Natalie is a Theatre Maker and Director specialising in devised physical and comical theatre performance ical s.
2501
Admin02.08.2021

Autoimmunity and infection in common variable immunodeficiency (CVID)

Improve the quality of our services and develop new ones• B and T cell abnormalities have been described in CVID.
4404
Admin08.07.2021

Patuzzo, Fabrizio

Kaplan-Meier survival and crude cumulative incidences of recurrence were estimated, and competing risks were taken into account.
5100
Admin03.09.2021

Patuzzo, Fabrizio

1 Andrea Maurichi, Rosalba Miceli, Tiziana Camerini, Luigi Mariani, Roberto Patuzzo, Roberta Ruggeri, Gianfranco Gallino, Elena Tolomio, Gabrina Tragni, Barbara Valeri, Andrea Anichini, Roberta Mortarini, Daniele Moglia, Mario Santinami, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico IRCCS , Istituto Nazionale dei Tumori, Milan; Giovanni Pellacani, Sara Bassoli, Caterina Longo, University Hospital of Modena and Skin Cancer Unit IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia; Pietro Quaglino, University Hospital of Turin, Turin; Nicola Pimpinelli, Lorenzo Borgognoni, University Hospital of Florence and Istituto Tumori Toscano, S.
9304
Admin16.08.2021

Before you continue to YouTube

001 were significantly associated with sentinel node positivity.
8000
Admin03.07.2021

Natalie Patuzzo

Moreover, we found statistical differences between the two groups of CVID patients: patients with ITP had a higher percentage of CD21 low cells.
6907
Admin01.09.2021

Autoimmunity and infection in common variable immunodeficiency (CVID)

Age, MR, ulceration, LVI, regression, and sentinel node status were independent predictors of survival and were used to construct a nomogram to predict 12-year overall survival.
31010
Admin19.08.2021

Before you continue to YouTube

DOI: Common variable immunodeficiency CVID is a heterogeneous group of diseases, characterized by primary hypogammaglobulinemia.
2306
Admin01.09.2021

Prediction of survival in patients with thin melanoma: results from a multi

Results: Median follow-up was 124 months interquartile range, 106 to 157 months ; 12-year overall survival was 85.
5009